185 related articles for article (PubMed ID: 25038562)
21. Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.
Grant RJ; Clarke PB
Neuroscience; 2002; 115(4):1281-94. PubMed ID: 12453497
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective Effects of Antidepressants via Upregulation of Neurotrophic Factors in the MPTP Model of Parkinson's Disease.
Shadfar S; Kim YG; Katila N; Neupane S; Ojha U; Bhurtel S; Srivastav S; Jeong GS; Park PH; Hong JT; Choi DY
Mol Neurobiol; 2018 Jan; 55(1):554-566. PubMed ID: 27975170
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment.
Luiten PG; Douma BR; Van der Zee EA; Nyakas C
Neurodegeneration; 1995 Sep; 4(3):307-14. PubMed ID: 8581563
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of striatal dopamine release by the L-type calcium channel inhibitor isradipine co-varies with risk factors for Parkinson's.
Brimblecombe KR; Connor-Robson N; Bataille CJR; Roberts BM; Gracie C; O'Connor B; Te Water Naude R; Karthik G; Russell AJ; Wade-Martins R; Cragg SJ
Eur J Neurosci; 2024 Mar; 59(6):1242-1259. PubMed ID: 37941514
[TBL] [Abstract][Full Text] [Related]
25. L-type Calcium Channels are Involved in Iron-induced Neurotoxicity in Primary Cultured Ventral Mesencephalon Neurons of Rats.
Xu YY; Wan WP; Zhao S; Ma ZG
Neurosci Bull; 2020 Feb; 36(2):165-173. PubMed ID: 31482520
[TBL] [Abstract][Full Text] [Related]
26. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
[TBL] [Abstract][Full Text] [Related]
27. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
Ding YM; Jaumotte JD; Signore AP; Zigmond MJ
J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
[TBL] [Abstract][Full Text] [Related]
28. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
29. Nimodipine enhances neurite outgrowth in dopaminergic brain slice co-cultures.
Sygnecka K; Heine C; Scherf N; Fasold M; Binder H; Scheller C; Franke H
Int J Dev Neurosci; 2015 Feb; 40():1-11. PubMed ID: 25447789
[TBL] [Abstract][Full Text] [Related]
30. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease.
Anekonda TS; Quinn JF; Harris C; Frahler K; Wadsworth TL; Woltjer RL
Neurobiol Dis; 2011 Jan; 41(1):62-70. PubMed ID: 20816785
[TBL] [Abstract][Full Text] [Related]
31. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
eNeuro; 2017; 4(6):. PubMed ID: 29177188
[TBL] [Abstract][Full Text] [Related]
33. Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine.
Sautter J; Kupsch A; Earl CD; Oertel WH
Exp Brain Res; 1997 Oct; 117(1):111-9. PubMed ID: 9386009
[TBL] [Abstract][Full Text] [Related]
34. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
Carvalho CA; Coutinho OP; Carvalho AP
J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
[TBL] [Abstract][Full Text] [Related]
35. Firing pattern modulation through SK channel current increase underlies neuronal survival in an organotypic slice model of Parkinson's disease.
Wang Y; Qu L; Wang XL; Gao L; Li ZZ; Gao GD; Yang Q
Mol Neurobiol; 2015 Feb; 51(1):424-36. PubMed ID: 24841382
[TBL] [Abstract][Full Text] [Related]
36. H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.
Fonseca CP; Gama S; Saavedra A; Baltazar G
Biochim Biophys Acta; 2014 Jul; 1842(7):927-34. PubMed ID: 24632468
[TBL] [Abstract][Full Text] [Related]
37. Nerve growth factor released from collagen scaffolds protects axotomized cholinergic neurons of the basal nucleus of Meynert in organotypic brain slices.
Foidl BM; Ucar B; Schwarz A; Rebelo AL; Pandit A; Humpel C
J Neurosci Methods; 2018 Feb; 295():77-86. PubMed ID: 29221639
[TBL] [Abstract][Full Text] [Related]
38. The effect of different durations of morphine exposure on mesencephalic dopaminergic neurons in morphine dependent rats.
Shi W; Ma C; Qi Q; Liu L; Bi H; Cong B; Li Y
Neurotoxicology; 2015 Dec; 51():51-7. PubMed ID: 26386147
[TBL] [Abstract][Full Text] [Related]
39. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
40. Comparing tonic and phasic dendritic calcium in cholinergic pedunculopontine neurons and dopaminergic substantia nigra neurons.
Chen RY; Evans RC
Eur J Neurosci; 2024 Apr; 59(7):1638-1656. PubMed ID: 38383047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
